Indiplon is hydrolyzed by arylacetamide deacetylase in human liver

M Shimizu, T Fukami, Y Ito, T Kurokawa, M Kariya… - Drug Metabolism and …, 2014 - ASPET
Human arylacetamide deacetylase (AADAC) catalyzes the hydrolysis of some clinically used
drugs, but the information available on its substrates is limited. To increase our knowledge of …

Arylacetamide deacetylase enzyme: presence and interindividual variability in human lungs

M Gabriele, P Puccini, M Lucchi, V Aprile… - Drug Metabolism and …, 2019 - ASPET
Human arylacetamide deacetylase (AADAC) is a single microsomal serine esterase
involved in the hydrolysis of many acetyl-containing drugs. To date, the presence and …

A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity

M Shimizu, T Fukami, Y Kobayashi, M Takamiya… - Drug Metabolism and …, 2012 - ASPET
Human arylacetamide deacetylase (AADAC) is responsible for the hydrolysis of clinically
used drugs such as flutamide, phenacetin, and rifamycins. Our recent studies suggested that …

Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse

Y Kobayashi, T Fukami, A Nakajima, A Watanabe… - Drug Metabolism and …, 2012 - ASPET
Human arylacetamide deacetylase (AADAC) is a major esterase responsible for the
hydrolysis of clinical drugs such as flutamide, phenacetin, and rifampicin. Thus, AADAC is …

Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases

T Fukami, M Kariya, T Kurokawa, A Iida… - European Journal of …, 2015 - Elsevier
Human arylacetamide deacetylase (AADAC) is an esterase responsible for the hydrolysis of
some drugs, including flutamide, indiplon, phenacetin, and rifamycins. AADAC is highly …

Isolation and characterization of arylacetamide deacetylase in cynomolgus macaques

Y Uno, M Hosokawa, T Imai - Journal of Veterinary Medical Science, 2015 - jstage.jst.go.jp
Arylacetamide deacetylase (AADAC), a microsomal serine esterase, hydrolyzes drugs, such
as flutamide, phenacetin and rifampicin. Because AADAC has not been fully investigated at …

Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase

K Yasuda, K Watanabe, T Fukami, S Nakashima… - Drug Metabolism and …, 2021 - Elsevier
Recently, in addition to carboxylesterases (CESs), we found that arylacetamide deacetylase
(AADAC) plays an important role in the metabolism of some clinical drugs. In this study, we …

Role of human arylacetamide deacetylase (AADAC) on hydrolysis of eslicarbazepine acetate and effects of AADAC genetic polymorphisms on hydrolase activity

K Hirosawa, T Fukami, K Tashiro, Y Sakai, F Kisui… - Drug Metabolism and …, 2021 - ASPET
Human arylacetamide deacetylase (AADAC) plays a role in the detoxification or activation of
drugs and is sometimes involved in the incidence of toxicity by catalyzing hydrolysis …

N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity

K Muta, T Fukami, M Nakajima, T Yokoi - Biochemical pharmacology, 2014 - Elsevier
Human arylacetamide deacetylase (AADAC) can hydrolyze clinical drugs such as flutamide,
phenacetin, and rifamycins. AADAC is a glycoprotein, but the role of glycosylation remains …

Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans

Y Sakai, T Fukami, M Nagaoka, K Hirosawa, H Ichida… - Life Sciences, 2021 - Elsevier
Aim Abiraterone acetate for metastatic castration-resistant prostate cancer is an acetylated
prodrug to be hydrolyzed to abiraterone. Abiraterone acetate is known to be hydrolyzed by …